2004
DOI: 10.1016/j.pbiomolbio.2004.02.004
|View full text |Cite
|
Sign up to set email alerts
|

Towards whole-organ modelling of tumour growth

Abstract: Multiscale approaches to modelling biological phenomena are growing rapidly. We present here some recent results on the formulation of a theoretical framework which can be developed into a fully integrative model for cancer growth. The model takes account of vascular adaptation and cell-cycle dynamics. We explore the effects of spatial inhomogeneity induced by the blood flow through the vascular network and of the possible effects of p27 on the cell cycle. We show how the model may be used to investigate the e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
55
0

Year Published

2006
2006
2013
2013

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 97 publications
(55 citation statements)
references
References 52 publications
0
55
0
Order By: Relevance
“…An explicit incorporation of other levels might lead to additional insights into the dynamics of the fracture healing process. In the simulation of tumour development and treatment, multi-scale models are frequently used to explicitly model the cell cycle and angiogenesis (Anderson & Chaplain 1998;Alarcon et al 2004) with the specific aim of the in silico design and testing of new therapies (Byrne et al 2006;McDougall et al 2006;Anderson & Quaranta 2008). Simulation results using the model of (i) Prendergast et al (1997) and (ii) Geris et al (2008d) showing the predicted tissues in the bone chamber after nine weeks for various implant displacement magnitudes.…”
Section: Prospectsmentioning
confidence: 99%
“…An explicit incorporation of other levels might lead to additional insights into the dynamics of the fracture healing process. In the simulation of tumour development and treatment, multi-scale models are frequently used to explicitly model the cell cycle and angiogenesis (Anderson & Chaplain 1998;Alarcon et al 2004) with the specific aim of the in silico design and testing of new therapies (Byrne et al 2006;McDougall et al 2006;Anderson & Quaranta 2008). Simulation results using the model of (i) Prendergast et al (1997) and (ii) Geris et al (2008d) showing the predicted tissues in the bone chamber after nine weeks for various implant displacement magnitudes.…”
Section: Prospectsmentioning
confidence: 99%
“…However, multi-scale models offer a distinct advantage in being able to integrate information across scales. Multi-scale modelling requires building and validating models at individual scales and linking them together in a method that is computationally feasible (Alarcon et al, 2004;Kirschner et al, 2007).…”
Section: Discussionmentioning
confidence: 99%
“…A range of multiscale models of tumour growth do incorporate cell cycle models at the cellular level (see e.g. [61]- [64]). These track intracellular levels of cyclins, cyclin dependent kinases (CDKs) and their inhibitors.…”
Section: Models Of Cellular Quiescence In Cancermentioning
confidence: 99%
“…The models of Alarcon and co-workers [61]- [63] link submodels of cancer growth at different spatial scales. At the subcellular level, progress though the cell cycle and the production of VEGF are modelled.…”
Section: Models Of Cellular Quiescence In Cancermentioning
confidence: 99%